Literature DB >> 30831570

Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping.

Jeeyong Kim1, Jeonghun Nam1, Woongsik Jang1, Chae Seung Lim2.   

Abstract

OBJECTIVE: TheAllplexTM Respiratory Panel 1 (ARP) is a new assay based on a real-time polymerase chain reaction (RT-PCR) for the detection of influenza A (Flu A), influenza B virus (Flu B), and respiratory syncytial virus (RSV), including subtyping by multiple detection temperature (MuDT) technology. We evaluated the performance of the Allplex Respiratory Panel compared to the SimplexaTM Flu A/B & RSV assay (SP) and other diagnostic tools.
MATERIALS AND METHODS: A total of 372 samples were collected from patients at the Korea University Guro Hospital in Seoul, Korea. All samples were tested for influenza virus and RSV by ARP, SP, and an in-house RT-PCR.
RESULTS: The sensitivity of ARP was 95.56, 100, and 95.24% for Flu A, Flu B, and RSV, respectively. The specificity of ARP was 100, 100, and 100% for Flu A, Flu B, and RSV, respectively. SP had sensitivities and specificities of 98.89 and 100% for Flu A, 100 and 100% for Flu B, and 100 and 100% for RSV.
CONCLUSION: The Allplex panelshowed high sensitivity, specificity, positive predictive, and negative predictive values for the detection of Flu A, Flu B, and RSV. This assay is fast and easy to perform because it takes only about 150 min and there is no need for post-PCR electrophoresis. The ARP can be used as a reliable and convenient assay in clinical laboratories.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  AllplexTMRespiratory Panel 1; Influenza; Real-time polymerase chain reaction; Respiratory syncytial virus; Respiratory virus

Mesh:

Year:  2019        PMID: 30831570      PMCID: PMC6639576          DOI: 10.1159/000499313

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  22 in total

Review 1.  Molecular diagnosis of respiratory viruses.

Authors:  Eric T Beck; Kelly J Henrickson
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

2.  Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.

Authors:  Alexandra J Lee; Suman R Das; Wei Wang; Theresa Fitzgerald; Brett E Pickett; Brian D Aevermann; David J Topham; Ann R Falsey; Richard H Scheuermann
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  A point-of-care diagnostic system to influenza viruses using chip-based ultra-fast PCR.

Authors:  Soon-Hwan Kwon; Sujin Lee; Jeyoun Jang; Yujin Seo; Hee-Young Lim
Journal:  J Med Virol       Date:  2018-02-27       Impact factor: 2.327

4.  Performance of a rapid antigen test (Binax NOW® RSV) for diagnosis of respiratory syncytial virus compared with real-time polymerase chain reaction in a pediatric population.

Authors:  Karen Miernyk; Lisa Bulkow; Carolynn DeByle; Lori Chikoyak; Kimberlee Boyd Hummel; Thomas Hennessy; Rosalyn Singleton
Journal:  J Clin Virol       Date:  2010-12-15       Impact factor: 3.168

Review 5.  Serial intervals of respiratory infectious diseases: a systematic review and analysis.

Authors:  Margaretha Annelie Vink; Martinus Christoffel Jozef Bootsma; Jacco Wallinga
Journal:  Am J Epidemiol       Date:  2014-10-07       Impact factor: 4.897

Review 6.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; D James Nokes; Bradford D Gessner; Mukesh Dherani; Shabir A Madhi; Rosalyn J Singleton; Katherine L O'Brien; Anna Roca; Peter F Wright; Nigel Bruce; Aruna Chandran; Evropi Theodoratou; Agustinus Sutanto; Endang R Sedyaningsih; Mwanajuma Ngama; Patrick K Munywoki; Cissy Kartasasmita; Eric A F Simões; Igor Rudan; Martin W Weber; Harry Campbell
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

7.  Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses.

Authors:  Kevin Alby; Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

8.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

9.  Evaluation of Seegene Allplex Respiratory Panel 1 kit for the detection of influenza virus and human respiratory syncytial virus.

Authors:  Laura Gimferrer; Cristina Andrés; Ariadna Rando; Maria Piñana; Maria Gema Codina; Maria Del Carmen Martin; Francisco Fuentes; Susana Rubio; Pilar Alcubilla; Tomàs Pumarola; Andrés Antón
Journal:  J Clin Virol       Date:  2018-05-25       Impact factor: 3.168

10.  Evaluation of Allplex Respiratory Panel 1/2/3 Multiplex Real-Time PCR Assays for the Detection of Respiratory Viruses with Influenza A Virus subtyping.

Authors:  Jaehyeon Lee; Hye Soo Lee; Yong Gon Cho; Sam Im Choi; Dal Sik Kim
Journal:  Ann Lab Med       Date:  2018-01       Impact factor: 3.464

View more
  1 in total

1.  Cepheid Xpert® Flu/RSV and Seegene Allplex RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice.

Authors:  Nasir Wabe; Robert Lindeman; Jeffrey J Post; William Rawlinson; Melissa Miao; Johanna I Westbrook; Andrew Georgiou
Journal:  Influenza Other Respir Viruses       Date:  2020-08-20       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.